Autoantibodies in sporadic creutzfeldt-jakob disease

JAMA Neurology

Volumn 70, Issue 7, 2013, Pages 919-922

  Angus Leppan, Heather ^a   Rudge, Peter ^b   Mead, Simon ^b   Collinge, John ^b   Vincent, Angela ^c  

^a ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

^b NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACLOFEN; BOTULINUM TOXIN; CARBIDOPA PLUS LEVODOPA; CLONAZEPAM; CYCLOPHOSPHAMIDE; GLYCINE RECEPTOR; IMMUNOGLOBULIN; PROTEIN 14 3 3; PROTEIN S100B; STEROID; VOLTAGE GATED POTASSIUM CHANNEL;

AGED; ANTIBODY SCREENING; APRAXIA; ARTICLE; ATAXIA; BRAIN BIOPSY; BRAIN FUNCTION; BURNING SENSATION; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; DEATH; DYSARTHRIA; DYSPHASIA; ELECTROENCEPHALOGRAPHY; FLUID RESUSCITATION; FRONTAL LOBE; GAIT DISORDER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INSOMNIA; IRRITABILITY; MALE; MUSCLE CONTRACTURE; MUSCLE REFLEX; MUSCLE RIGIDITY; MUSCLE SPASM; MYOCLONUS; MYOKYMIA; PERSONALITY DISORDER; PLASMAPHERESIS; PRIORITY JOURNAL; SEPSIS; SEPTIC SHOCK; SPASTICITY; SPORADIC CREUTZFELDT JAKOB DISEASE; SWEATING; WASTING SYNDROME;

EID: 84880312785     PISSN: 21686149     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaneurol.2013.2077     Document Type: Article

References (14)

1. Khalili-Shirazi A, Quaratino S, Londei M, et al. Protein conformation significantly influences immune responses to prion protein. J Immunol. 2005;174(6):3256-3263.
2. Irani SR, Pettingill P, Kleopa KA, et al. Morvan syndrome: clinical and serological observations in 29 cases. Ann Neurol. 2012;72(2):241-255.
3. Mas N, Saiz A, Leite MI, et al. Antiglycinereceptor encephalomyelitis with rigidity. J Neurol Neurosurg Psychiatry. 2011;82(12):1399-1401.
4. Geschwind MD, Tan KM, Lennon VA, et al. Voltage-gated potassium channel autoimmunity mimicking Creutzfeldt-Jakob disease. Arch Neurol. 2008;65(10):1341-1346.
5. Vincent A, Bien CG, Irani SR, Waters P. Autoantibodies associated with diseases of the CNS: new developments and future challenges. Lancet Neurol. 2011;10(8):759-772.
6. Bien CG, Vincent A, Barnett MH, et al. Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis. Brain. 2012;135(pt 5):1622-1638.
7. Lloyd S, Mead S, Collinge J. Genetics of prion disease. Top Curr Chem. 2011;305:1-22.
8. Ishida C, Okino S, Kitamoto T, Yamada M. Involvement of the peripheral nervous system in human prion diseases including dural graft associated Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry. 2005;76(3):325-329.
9. Zerr I, Kallenberg K, Summers DM, et al. Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain. 2009;132(pt 10): 2659-2668.
10. Hyare H, Thornton J, Stevens J, et al. High-b-value diffusionMR imaging and basal nuclei apparent diffusion coefficient measurements in variant and sporadic Creutzfeldt-Jakob disease. AJNR Am J Neuroradiol. 2010;31(3):521-526.
11. Skinningsrud A, Stenset V, Gundersen AS, Fladby T. Cerebrospinal fluid markers in Creutzfeldt-Jakob disease. Cerebrospinal Fluid Res. 2008;5:14.
12. Steinhoff BJ, Räcker S, Herrendorf G, et al. Accuracy and reliability of periodic sharp wave complexes in Creutzfeldt-Jakob disease. Arch Neurol. 1996;53(2):162-166.
13. Mackay G, Ahmad K, Stone J, et al. NMDA receptor autoantibodies in sporadic Creutzfeldt-Jakob disease. J Neurol. 2012;259(9): 1979-1981.
14. Fujita K, Yuasa T, Takahashi Y, et al. Antibodies to N-methyl-D-aspartate glutamate receptors in Creutzfeldt-Jakob disease patients. J Neuroimmunol. 2012;251(1-2):90-93.